Results 21 to 30 of about 37,260 (216)

Lupus Nephritis and Dysbiosis

open access: yesBiomedicines, 2023
Lupus nephritis (LN) is one of the most common and serious complications of systemic lupus erythematosus (SLE). The risk factors for developing LN by SLE patients are not fully understood. They are considered to be a mix of genetic and environmental variables, one of them being dysbiosis, proposed recently to interfere with autoimmunity. As of yet, the
Marta Monticolo   +2 more
openaire   +3 more sources

Lupus Nephritis in Children: Novel Perspectives

open access: yesMedicina, 2023
Childhood-onset systemic lupus erythematosus is an inflammatory and autoimmune condition characterized by heterogeneous multisystem involvement and a chronic course with unpredictable flares.
Marco Pennesi, Simone Benvenuto
doaj   +1 more source

Lupus nephritis

open access: yesKidney International, 1997
Contains fulltext : 24337___.PDF (Publisher’s version ) (Open Access)
openaire   +3 more sources

Neutrophil gelatinase-associated lipocalin is a urine-based biomarker for diagnosing active lupus nephritis

open access: yesBangabandhu Sheikh Mujib Medical University Journal
Background: Lupus nephritis is one of the most serious complications of systemic lupus erythematosus (SLE). Urinary neutrophil gelatinase-associated lipocalin (NGAL) is a non-invasive biomarker that may aid in diagnosing active lupus nephritis.
Anthony Chakma   +4 more
doaj   +1 more source

Spectrum of renal vascular lesions among patients with lupus nephritis: An experience from a tertiary care center

open access: yesIndian Journal of Pathology and Microbiology, 2023
Background: Lupus nephritis (LN) is the assemblage of glomerular, tubulointerstitial and vascular changes. Despite the fact that glomerular changes are overemphasized in pathological classification and scoring system, but the existence of vascular damage
Madhumita Paul   +5 more
doaj   +1 more source

The Pathogenesis of Lupus Nephritis [PDF]

open access: yesJournal of the American Society of Nephrology, 2013
Lupus nephritis is an immune complex GN that develops as a frequent complication of SLE. The pathogenesis of lupus nephritis involves a variety of pathogenic mechanisms. The extrarenal etiology of systemic lupus is based on multiple combinations of genetic variants that compromise those mechanisms normally assuring immune tolerance to nuclear ...
Maciej, Lech, Hans-Joachim, Anders
openaire   +2 more sources

Comparison of clinicopathological characteristics among adult patients with early and delayed lupus nephritis

open access: yesJournal of the Pakistan Medical Association
Objective: To assess clinicopathological characteristics in adult patients with early and delayed lupus nephritis. Method: The comparative, cross-sectional study was conducted at the Department of Nephrology, Sindh Institute of Urology and ...
Anmol   +3 more
doaj   +1 more source

Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus

open access: yesArthritis Care &Research, EarlyView.
Objective Economic insecurities, such as food, housing, transportation, and financial challenges, are modifiable risk factors and influence patient‐reported outcomes (PROs) in systemic lupus erythematosus (SLE). We examined the following: (1) associations between economic insecurities and PROs, and (2) the impact of screening and addressing economic ...
Jay Patel   +8 more
wiley   +1 more source

Clinical profile of patients with lupus nephritis

open access: yesReumatismo, 2011
To the Editor Lupus nephritis is the strongest predictor of systemic lupus erythematosus (SLE) patient’s morbidity and mortality with a prevalence varying from 31 to 65% according to the studied population (1).
A.C. Schönrock, T.L. Skare
doaj   +1 more source

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

open access: yesArthritis Care &Research, EarlyView.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy